Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001140361-14-012591)

Filing Details

Accession Number:: 0001140361-14-012591
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-03-13 16:13:24
Reporting Period:: 2014-03-12

Filing Date:: 2014-03-13
Accepted Time:: 2014-03-13 16:13:24
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1367644	Emergent Biosolutions Inc.	EBS	Pharmaceutical Preparations (2834)	141902018

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1514588	Adam Havey	2273 Research Blvd. Suite 400 Rockville MD 20853	Evp, Biodefense Divison	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2014-03-12	775	$27.15	36,145	No	4	F	Direct
Common Stock	Acquisiton	2014-03-12	11,562	$18.90	47,707	No	4	M	Direct
Common Stock	Disposition	2014-03-12	11,562	$27.50	36,145	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	F	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (right to buy)	Disposition	2014-03-12	11,562	$0.00	11,562	$18.90

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2016-03-09	No	4	M	Direct

Footnotes

Consists of restricted stock units granted under the Second Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan.
The option is fully vested.